David Roth, Chief Medical Officer at Syros Pharmaceuticals, Inc. (SYRS), sold 20,902 shares at $4.95 ($103K) on 2024-04-03, disclosed to the SEC on 2024-04-05.
Scheduled sale ($103k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.95 | 10,451 | $52K | 50.0% |
| 2 | $4.95 | 10,451 | $52K | 50.0% |
| Total | $4.95 avg | 20,902 | $103K | 100% |
| Filing → |
| SYRS | SELL | 2023-12-14 | $31K | — | Filing → |
| SYRS | SELL | 2023-12-08 | $25K | — | Filing → |
| SYRS | SELL | 2023-08-02 | $29K | — | Filing → |